Balaxi Pharmaceuticals - News
NSE: BALAXI
₹22.43
As on 25-Sep-2026 09:08IST
Market cap
₹125 Cr
Revenue (TTM)
₹280 Cr
P/E Ratio
51.8
P/B Ratio
0.5
Div. Yield
0 %
Announcements
View AnnouncementsAlteration Of Capital and Fund Raising-XBRL
25-Jan-2024No News & Announcements are available.